Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer?
  1. Home
  2. Publications
  3. Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer?

Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer?

Authors:
  • AKA Kleespies
    A Kleespies
  • KJK Jauch
    K Jauch
  • CBC Bruns
    C Bruns

Publisher website
Google Scholar
  • 1 February 2006
    • journal article
    • review article
    • Published by Elsevier in Drug Resistance Updates
    • Vol. 9  (1-2) , 1-18
    • DOI:10.1016/j.drup.2006.02.002
    • PMID:16621676
Abstract
No abstract available
Keywords
  • MOLECULAR TARGETING
  • EGFR
  • VEGFR
  • PDGFR
  • SIGNAL TRANSDUCTION
  • SRC
  • TKI
  • RECEPTOR TYROSINE KINASE
  • RTK
  • GEMCITABINE
  • TARGETED THERAPY
  • TYROSINE KINASE INHIBITOR
  • TYROSINE KINASE
  • MONOCLONAL ANTIBODY
Cited by 48 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.